Covid-19 vaccine's largest buyers

vaccinMany countries are racing to ensure a minimum supply of Covid-19 vaccine doses. According to a report by the NGO Oxfam, a group of countries representing 13 percent of the world's population has pre-purchased 50 percent of the future vaccine doses.

India

India alone is ahead of the European Union and the United States. The country has pre-ordered 1.6 billion doses. The orders were placed with AstraZeneca, Pfizer/BioNTech and Novavax.

The European Union

The European Commission is in charge of defining the vaccine supply strategy. It has ordered 1.4 billion doses for member countries, of which 15% are destined for France. The pre-orders are distributed as follows:

  • 400 million doses from AstraZeneca
  • 400 million doses from Johnson & Johnson
  • 300 million doses from Sanofi-GSK
  • 300 million doses from Pfizer/BioNTech

United States

The U.S. has ordered more than 1 billion doses from six laboratories. This order includes:

  • 300 million doses of AstraZeneca's vaccine
  • 100 million doses of Pfizer/BioNTech vaccine
  • 100 million doses of Novavax vaccine
  • 100 million doses of Sanofi-GSK and Johnson & Johnson vaccines
  • 100 million doses of Moderna® vaccine

Canada

With a population of 38 million people, Canada has pre-ordered 358 million doses from seven different laboratories. Such massive order recognizes that some vaccines may fail clinical testing or validation by the Agency for Drugs and Technologies in Health:

  • 76 million doses from Medicago
  • 76 million doses from Novavax
  • 72 million doses from Sanofi/GSK
  • 56 million doses from Pfizer/BioNTech
  • 38 million doses from Janssen Pharmaceutical Companies
  • 20 million doses from AstraZenecal
  • 20 million doses from Moderna

United Kingdom

The United Kingdom has already placed an order for 350 million doses with six laboratories, including:

  • 100 million doses from AstraZenecal
  • 60 million doses with Novavax
  • 60 million doses from Sanofi-GSK
  • 40 million doses from Pfizer/BioNTech

Read also | Covid-19 vaccine: poor countries will have to wait

0
Your rating: None
Advertising Program          Terms of Service          Copyright          Useful links          Social networks          Credits